牙过敏管理的一次性关联性协议:为期一年的随机盲目的临床研究
Thayna Carolina Zeni1, Poliana Maria de Faveri Cardoso1, Rafael da Silva Vanolli1
1Department of Restorative Dentistry, School of Dentistry, Western State University of Paraná, Cascavel, PR, Brazil.
Restorative dentistry & endodontics
|June 6, 2024
概括
这项研究评估了单次治疗牙过敏症 (DH) 的治疗方法. 所有测试的协议都有效地控制了多达12个月的DH,在对照组和Remineralizing Desensitizing Protocol (PDR) 组中观察到显著的结果.
科学领域:
- 牙科 牙科是指牙科的专业.
- 牙科材料科学 牙科材料科学
- 临床研究 临床研究
背景情况:
- 牙过敏症 (DH) 是一种常见的临床疾病.
- 非恢复性治疗旨在缓解DH的症状,而不需要侵入性手术.
- 一次性治疗方案提供了一种方便的治疗方法.
研究的目的:
- 建立和评估一个单次会议的关联性协议,用于牙过敏症 (DH) 的非恢复性治疗.
- 为了比较不同无敏剂在12个月的有效性.
主要方法:
- 这是一项分口研究,涉及24名患有DH的个体 (VAS最低分数为4).
- 评估了四个治疗组:对照组 (通用粘合剂),神经脱敏协议 (5%酸盐),混合脱敏协议 (PAM:5%化和5%酸盐) 和重矿化脱敏协议 (PDR:表面部分反应玻璃技术光聚合漆).
- 视觉模拟尺度 (VAS) 敏感性测试在应用后立即进行,并在1周,1个月,2个月和12个月后进行.
主要成果:
- 所有治疗组在12个月评估时,与基线相比,DH得分在统计学上显著下降.
- 在12个月后,在PAM组,对照组和PDR组之间发现了显著的差异.
- 对照组和PDR组显示出特别显著的结果.
结论:
- 所有评估的单次疗程无敏化方案都有效地管理牙过敏.
- 对照组和重矿化脱敏协议 (PDR) 组取得了显著的长期结果.
- 单次疗程无敏化方案可以在长达12个月的时间内提供有效的DH控制.
更多相关视频
06:06Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
2.5K
07:39Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay
Published on: July 26, 2022
3.6K
相关概念视频
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.